Advertisement
Advertisement
MYGN
Myriad Genetics Inc
3.98
USDSponsored
+0.10
+2.45%
Sep 16, 13:55 UTC -4
Open
MYGN Earnings Reports
Positive Surprise Ratio
MYGN beat 18 of 23 last estimates.
78%
Next Report
Date of Next Report
Nov 02, 2026
Estimate for Q3 26 (Revenue/ EPS)
$195.26M
/-$0.21
Implied change from Q2 26 (Revenue/ EPS)
+2.39%
/-16.00%
Implied change from Q3 25 (Revenue/ EPS)
-5.07%
/--
Myriad Genetics Inc earnings per share and revenue
On Jul 30, 2026, MYGN reported earnings of -0.25 USD per share (EPS) for Q2 26, missing the estimate of -0.05 USD, resulting in a -323.73% surprise. Revenue reached 190.70 million, compared to an expected 210.15 million, with a -9.26% difference. The market reacted with a -46.74% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 13 analysts forecast an EPS of -0.21 USD, with revenue projected to reach 195.26 million USD, implying an decrease of -16.00% EPS, and increase of 2.39% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Attovia Therapeutics, Inc. Common Stock
Report Date
Sep 02, 2026 For Q2 26
Estimate
-$2.78
Actual
-$4.88
Surprise
-75.25%
Scribe Therapeutics Inc. Common Stock
Report Date
Sep 02, 2026 For Q2 26
Estimate
-$3.03
Actual
-$2.62
Surprise
+13.59%
enGene Therapeutics Inc. Common Stock
Report Date
Sep 08, 2026 For Q3 26
Estimate
-$0.43
Actual
-$0.47
Surprise
-7.16%
Anixa Biosciences, Inc.
Report Date
Sep 09, 2026 For Q3 26
Estimate
-$0.08
Actual
-$0.08
Surprise
+8.78%
Alzamend Neuro, Inc. Common Stock
Report Date
Sep 10, 2026 For Q1 27
Estimate
-$0.57
Actual
-$0.68
Surprise
-19.05%
FAQ
What were Myriad Genetics Inc's earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Myriad Genetics Inc reported EPS of -$0.25, missing estimates by -323.73%, and revenue of $190.70M, -9.26% below expectations.
How did the market react to Myriad Genetics Inc's Q2 2026 earnings?
The stock price moved down -46.74%, changed from $5.37 before the earnings release to $2.86 the day after.
When is Myriad Genetics Inc expected to report next?
The next earning report is scheduled for Nov 02, 2026.
What are the forecasts for Myriad Genetics Inc's next earnings report?
Based on 13
analysts, Myriad Genetics Inc is expected to report EPS of -$0.21 and revenue of $195.26M for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.